ArticleInflammopharmacology2026

Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer's pathology through amyloidogenic and inflammatory pathways: experimental and computational evidence.

Varnita Karmakar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.